Elizabeth Geis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Elizabeth Geis has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- James B. Adams
School for Engineering of Matter, Transport and Energy, Arizona State University, Tempe, AZ 85281, USA
5 shared publications - Jessica Mitchell
Southwest College of Naturopathic Medicine, Tempe, AZ 85282, USA
5 shared publications - David Quig
Doctor’s Data, St. Charles, IL 60174, USA
4 shared publications - Tapan Audhya
Health Diagnostics, South Amboy, NJ 08879, USA
4 shared publications - Eva Gehn
Autism Research Institute, San Diego, CA, USA
3 shared publications - Julie Ingram
Autism Research Institute, San Diego, CA, USA
3 shared publications
Latest Publications
- Top Cited PapersOpen Access
Comprehensive Nutritional and Dietary Intervention for Autism Spectrum Disorder—A Randomized, Controlled 12-Month Trial
This study involved a randomized, controlled, single-blind 12-month treatment study of a comprehensive nutritional and dietary intervention. Participants were 67 children and adults with autism spectrum disorder (ASD) ages 3–58 years from Arizona and 50 non-sibling neurotypical controls of similar age and gender. Treatment began with a special vitamin/mineral supplement, and additional treatments were added sequentially, including essential fatty acids, Epsom salt baths, carnitine, digestive enzymes, and a healthy gluten-free, casein-free, soy-free (HGCSF) diet. There was a significant improvement in nonverbal intellectual ability in the treatment group compared to the non-treatment group (+6.7 ± 11 IQ points vs. −0.6 ± 11 IQ points, p = 0.009) based on a blinded clinical assessment. Based on semi-blinded assessment, the treatment group, compared to the non-treatment group, had significantly greater improvement in autism symptoms and developmental age. The treatment group had significantly greater increases in EPA, DHA, carnitine, and vitamins A, B2, B5, B6, B12, folic acid, and Coenzyme Q10. The positive results of this study suggest that a comprehensive nutritional and dietary intervention is effective at improving nutritional status, non-verbal IQ, autism symptoms, and other symptoms in most individuals with ASD. Parents reported that the vitamin/mineral supplements, essential fatty acids, and HGCSF diet were the most beneficial.
Top Cited PapersOpen AccessComprehensive Nutritional and Dietary Intervention for Autism Spectrum Disorder—A Randomized, Controlled 12-Month Trial
This study involved a randomized, controlled, single-blind 12-month treatment study of a comprehensive nutritional and dietary intervention. Participants were 67 children and adults with autism spectrum disorder (ASD) ages 3–58 years from Arizona and 50 non-sibling neurotypical controls of similar age and gender. Treatment began with a special vitamin/mineral supplement, and additional treatments were added sequentially, including essential fatty acids, Epsom salt baths, carnitine, digestive enzymes, and a healthy gluten-free, casein-free, soy-free (HGCSF) diet. There was a significant improvement in nonverbal intellectual ability in the treatment group compared to the non-treatment group (+6.7 ± 11 IQ points vs. −0.6 ± 11 IQ points, p = 0.009) based on a blinded clinical assessment. Based on semi-blinded assessment, the treatment group, compared to the non-treatment group, had significantly greater improvement in autism symptoms and developmental age. The treatment group had significantly greater increases in EPA, DHA, carnitine, and vitamins A, B2, B5, B6, B12, folic acid, and Coenzyme Q10. The positive results of this study suggest that a comprehensive nutritional and dietary intervention is effective at improving nutritional status, non-verbal IQ, autism symptoms, and other symptoms in most individuals with ASD. Parents reported that the vitamin/mineral supplements, essential fatty acids, and HGCSF diet were the most beneficial.
- Open Access
- 12 December 2011
- Published by Springer Nature in BMC Pediatrics
- Vol. 11 (1) , 111
Effect of a vitamin/mineral supplement on children and adults with autism
Vitamin/mineral supplements are among the most commonly used treatments for autism, but the research on their use for treating autism has been limited.
- 12 December 2011
- Published by Springer Nature in BMC Pediatrics
- Vol. 11 (1) , 111
Open AccessEffect of a vitamin/mineral supplement on children and adults with autism
Vitamin/mineral supplements are among the most commonly used treatments for autism, but the research on their use for treating autism has been limited.
- Open Access
- 1 January 2011
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 8 (1) , 34
Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity
The relationship between relative metabolic disturbances and developmental disorders is an emerging research focus. This study compares the nutritional and metabolic status of children with autism with that of neurotypical children and investigates the possible association of autism severity with biomarkers.
- 1 January 2011
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 8 (1) , 34
Open AccessNutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity
The relationship between relative metabolic disturbances and developmental disorders is an emerging research focus. This study compares the nutritional and metabolic status of children with autism with that of neurotypical children and investigates the possible association of autism severity with biomarkers.
- Open Access
- 23 October 2009
- Published by Springer Nature in BMC Clinical Pharmacology
- Vol. 9 (1) , 17
Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part B - Behavioral results
This study investigated the effects of oral dimercapto succinic acid (DMSA) therapy on the behavioural symptoms of children with autism spectrum disorders (ASD) ages 3-8 years.
- 23 October 2009
- Published by Springer Nature in BMC Clinical Pharmacology
- Vol. 9 (1) , 17
Open AccessSafety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part B - Behavioral results
This study investigated the effects of oral dimercapto succinic acid (DMSA) therapy on the behavioural symptoms of children with autism spectrum disorders (ASD) ages 3-8 years.